| Literature DB >> 35908288 |
Ying Wang1, Hongyu Chen1, Liang Ma2, Ming Gong1, Yingying Wu1, Dapeng Bao1, Gen Zou1.
Abstract
Given their lignocellulose degradability and biocontrol activities, fungi of the ubiquitously distributed genus Trichoderma have multiple industrial and agricultural applications. Genetic manipulation plays a valuable role in tailoring novel engineered strains with enhanced target traits. Nevertheless, as applied to fungi, the classic tools of genetic manipulation tend to be time-consuming and tedious. However, the recent development of the CRISPR-Cas system for gene editing has enabled researchers to achieve genome-wide gene disruptions, gene replacements, and precise editing, and this technology has emerged as a primary focus for novel developments in engineered strains of Trichoderma. Here, we provide a brief overview of the traditional approaches to genetic manipulation, the different strategies employed in establishing CRSIPR-Cas systems, the utilization of these systems to develop engineered strains of Trichoderma for desired applications, and the future trends in biotechnology.Entities:
Mesh:
Year: 2022 PMID: 35908288 PMCID: PMC9518982 DOI: 10.1111/1751-7915.14126
Source DB: PubMed Journal: Microb Biotechnol ISSN: 1751-7915 Impact factor: 6.575
FIGURE 1Schematic diagrams of classical transformation strategies in Trichoderma species. (A) Polyethylene glycol (PEG)–mediated transformation of protoplasts (PMT). (B) Agrobacterium tumefaciens‐mediated transformation (AMAT). (C) Electroporation. (D) Biolistic delivery. In general, PMT (A), electroporation (C), and biolistic delivery (D) are theoretically compatible with various biomolecules such as linear or circular DNA, RNA, protein, ribonucleoprotein. However, plasmid, ligated with a selectable marker (red) and an expression cassette of a gene of interest (light blue), is the most common biomolecule for transformation. In AMAT (B), the biomolecule is be limited to DNA fragments which is flanked by left border (purple) and right border (green). These plasmids all contain kanamycin, ampicillin, or other antibiotic resistance in their skeletons, enabling screening and propagation in Escherichia coli.
CRISPR‐Cas systems established in Trichoderma species
| Species | Strategies | Editing type and application | Efficiency | Reference | ||
|---|---|---|---|---|---|---|
| Cas | gRNA | Transformation method | ||||
|
|
| Transcribed in vitro | AMAT (Cas9) and PEG (gRNA) | Single/multiple gene disruption or replacement; | 4.2% (triplex) –100% (single) | Liu et al. ( |
|
|
| Transcribed in vitro | PMT | Single‐gene replacement; gene function investigation | N/A | Liu, Chen et al. ( |
|
| RNP | RNP | PMT | Single‐gene disruption | 3.5% ( | Hao and Su ( |
|
| RNP | RNP | PMT | Single/triple gene replacement; chassis modification; strain engineering | 6% (double) –23% (single); 12% (triple) | Rantasalo et al. ( |
|
|
| U6 snRNA promoter | AMAT | Single‐gene disruption | 1–10% | Wu, Chen, Huang, et al. ( |
|
| RNP | RNP | PMT | Single‐gene replacement; strain engineering | 100% | Vidgren et al. ( |
|
| RNP | RNP | PMT | Single/multiple gene disruption or replacement; marker‐free gene disruption | 7.4% (marker free) –100% (single); 10.0% (triple) | Zou, Bao et al. ( |
|
|
| 5S rRNA promoter | PMT | Single‐gene disruption | 6.7% (heterologous 5S rRNA promoter) –36.7% (native 5S rRNA promoter) | Wang et al. ( |
|
| RNP | RNP | PMT | Single‐gene replacement; marker‐recycled iterative replacement; chassis modification | N/A | Chai et al. ( |
|
|
| 5S rRNA promoter | PMT | Single‐gene disruption | 6.7% (heterologous 5S rRNA promoter) –36.7% (native 5S rRNA promoter) |
Wang et al. ( |
|
|
| U6 snRNA promoter with 1st intron | PMT | Single‐gene replacement; gene function investigation | N/A | Bodie et al. ( |
|
|
|
| Biolistic transformation | Single‐gene disruption | N/A | Vieira et al. ( |
|
| RNP | RNP | PMT | Single/double gene disruption | N/A | Primerano ( |
FIGURE 2Schematic diagrams of CRISPR‐Cas systems in Trichoderma species. (A) Cas9‐expressing chassis with gRNA in vitro. Cas9‐expression cassette containing the codon‐optimized cas9 gene with NLS (light blue) is controlled by an appropriate promoter (red) and terminator (purple). gRNA (yellow: crRNA spacer sequence; sapphire: tracrRNA) is transcribed using T7 promoter in vitro and then is transformed with Cas9‐expressing chassis cells. (B) Plasmid‐based CRISPR‐Cas. Cas9‐expression cassette and gRNA‐transcription cassette can be constructed in a plasmid or separately in two plasmids. (C) RNP‐based CRISPR‐Cas. RNP is pre‐assembled with Cas9 and gRNA in vitro and transformed within cells.
FIGURE 3Schematic diagram of marker‐recycling based on uracil auxotrophy. The optimized deletion construct included a bidirectional marker (e.g. ura5) (celadon), the 5′ (yellow) and 3′ (pink) flanking region of the target gene (grey), and the 5′ direct repeat (purple), that is, the upstream sequence of the 5′ flanking region. The donor DNA together with the in vitro preassembled RNP was transformed into the auxotrophic strain synchronously to generate edited prototrophic transformants. The bidirectional marker on the transformant genome was recycled via homologous recombination between two direct repeat fragments after incubation on screening plates (e.g. under selection of 5‐FOA). By contrast, transformants with ectopic integration of donor DNA were unable to recycle the bidirectional marker due to a shortage of the essential 5′ direct repeat for homologous recombination.